Lashaundra Marie Thedford Adley, MD
NPI 1104069228ActiveIndividual· General Practice· Mexia, TX
Opted out of Medicare from May 2026 to May 2028. General Practice (MD) in Mexia, Texas, licensed in AL and TX, with an NPI issued in April 2009. Their prescriptions cost Medicare Part D more than their services did: $879,664 for 6,017 claims, against $9,955 paid for services in 2024. Novo Nordisk Inc was the largest of 9 companies reporting payments in 2025, $387.21 in all, mostly food and beverage.
Overview
| NPI | 1104069228 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Apr 20, 2009 |
| Last updated in NPPES | Sep 5, 2025 |
| Certified by provider | Sep 5, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| General Practice Primary | 208D00000X | 37174 | AL |
| Pediatrics | 208000000X | P7361 | TX |
| Pediatrics | 208000000X | MD.37174 | AL |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out May 11, 2026 – May 11, 2028 |
| Can order and refer | No |
| Accepts assignment | Yes (participating) |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Medicare services in 2024
| Medicare patients | 49 |
|---|---|
| Services billed | 221 across 21 procedure codes |
| Paid by Medicare | $9,955 |
Part D prescriptions in 2024
| Prescriptions (claims) | 6,017 · 11,493 30-day fills |
|---|---|
| Patients | 191 |
| Total drug cost | $879,664 |
| Generic share | 81% of claims |
Industry payments (Open Payments)
- 2025$387.21 · 21 payments from 9 companies
- 2024$1,239 · 75 payments from 17 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novo Nordisk Inc | $101.96 | 5 |
| Astrazeneca Pharmaceuticals LP | $69.67 | 4 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.30 | 3 |
| Lilly USA, LLC | $52.95 | 3 |
| Bayer Healthcare Pharmaceuticals Inc. | $33.39 | 2 |
What the 2025 payments were for
- Food and Beverage$387.21 · 21 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other general practitioners in Mexia
- 1487757902